No study is open for enrollment. MenGenics Research Program has no active, recruiting, or completed study. This page exists so that the standard is public before the first study exists — and so that anyone can hold us to it.
What every study on this page will show, before anyone can enroll
When a study opens, it will appear here with all of the following. If any field is missing, the study is not open.
Template
Study title
- Registration
- ClinicalTrials.gov identifier (NCT number), linked. Every interventional study is registered before enrollment begins.
- Status
- Concept · Protocol Development · Recruiting · Active, not recruiting · Analysis · Completed · Published.
- Principal Investigator
- Name, U.S. medical license and state, institutional affiliation.
- Ethics oversight
- The named Institutional Review Board (IRB) that reviewed and approved the protocol, and the approval date.
- Design and phase
- Observational or interventional, and the phase where applicable.
- Eligibility
- Who may participate and who may not, in plain language.
- Informed consent
- What participation involves, its risks and benefits, and the right to withdraw at any time.
- Funding and conflicts
- Who pays for the study, and every relevant financial interest of the investigators and of the Program.
- Contact
- A direct contact for questions, and the IRB contact for participant rights.
Two things worth understanding before any study opens
What an IRB is. An Institutional Review Board is an independent committee — including people who are not part of the Program — that reviews a research protocol before it begins. Its job is to protect participants: it can require changes, and it can refuse approval. No human-subject study of ours will begin without one.
What informed consent means. Consent is not a signature on a form. It means you were told, in language you understand, what the study involves, what could go wrong, what the alternatives are, and that you may stop at any time without losing anything you are otherwise entitled to. If any of that is missing, do not sign.
Our current commitments
- Every interventional study will be registered on ClinicalTrials.gov before the first participant is enrolled, and the identifier will be published here.
- The Principal Investigator and the reviewing IRB will be named here, not described in general terms.
- Study materials, consent forms, and plain-language summaries will be published in English and Spanish. The Program serves a bilingual population; consent in a language you do not fully read is not consent.
- Results will be published whether or not they favor MenGenics, and the funding relationship will be disclosed in the publication.
- Joining a mailing list, sending a collaboration inquiry, or contacting us never enrolls anyone in anything.
How the Program is funded today
The Program is currently funded entirely by MenGenics, the commercial men's health platform of which it is a division. There is no external grant, sponsor, or industry funding at this time. Any future funding source will be named on the study it supports.
Research lines under development — none of them enrolling — are described on our Research page.
